Perennial’s trust added to BT, Macquarie Wrap
The Perennial Value Microcap Opportunities Trust has been added to the Macquarie Wrap platform, as well as to BT platforms, BT Panorama, BT Wrap and Asgard.
The Trust invests in a range of listed and unlisted companies comprised of small and microcap stocks, with a market capitalisation of less than $500 million while leveraging the experience of Perennial’s smaller companies team.
Perennial Value’s managing director, John Murray, said: “The cornerstone of the fund’s approach is a strong emphasis on company research and value.”
“The aim is to develop a detailed understanding of each company before committing investors’ funds and unearthing investment opportunities that are missed by the broader market.”
The trust would also provide the ability to invest in pre-IPO opportunities, another area in which retail investors were not well exposed, the company said.
Since its inception in February, 2017, the fund delivered a return of 44 per cent, net of fees, outperforming the S&P/ASX Small Ordinaries Accumulation Index by 21 per cent.
According to Perennial Value’s head of smaller companies and micro caps, Andrew Smith, every potential opportunity was assessed on its key qualitative and quantitative criteria, including “sound financial position (low debt), good management, demonstrable track record of profit or a clear path to this, as well as strong market position.”
“In Microcaps we are focused on companies with strong growth (measured by three year EPS growth) with a combination of an attractive valuation and a strong balance sheet (both are captured in the enterprise value to earnings measure),” he said.
“We constantly evaluate the market to ensure our portfolio provides the best combination of value and growth at any one time.”
The Perennial Value Microcap Opportunities Trust received a ‘recommended’ rating from both Lonsec and Zenith.
The trust was also available on Hub24, Netwealth (IDPS), Powerwrap and Mason Stevens platforms.
AUTHOR
Oksana Patron
Recommended for you
Global X has painted a worrying picture for active ETFs in Australia, with investor adoption proving uneven and the popularity of its low-cost index counterparts only growing stronger.
Australian equity ETFs attracted record inflows of $3.2 billion in 1Q25, while heightened volatility led to a decline in flows for global equity ETFs, according to Vanguard.
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline 52 per cent year-to-date and hit its funds under management, quarterly flows show.
GQG Partners has revealed its quarterly flows for the first three months of 2025 were up 5.8 per cent, after a difficult final quarter of 2024 as a result of institutional redemptions.
